Join to View Full Profile
125 16th Ave ESeattle, WA 98112
Phone+1 206-326-3000
Dr. Arterburn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1997 - 2000
University of Kentucky College of MedicineClass of 1997
Certifications & Licensure
WA State Medical License 2001 - 2026
OH State Medical License 2003 - 2007
TX State Medical License 1998 - 2002
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study Testing Patient Decision Tools Related to the Risks and Benefits of Weight Loss Surgery Start of enrollment: 2008 May 01
- Comparing the Benefits and Harms of Three Types of Weight Loss Surgery -- The PCORnet® Bariatric Study Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesi...Donald C Simonson, William F Gourash, David E Arterburn, Bo Hu, Sangeeta R Kashyap
Diabetes Care. 2025-04-01 - Health Expenditures of Patients With Diabetes After Bariatric Surgery: Comparing Gastric Bypass and Sleeve Gastrectomy.Matthew L Maciejewski, Lindsay Zepel, Valerie A Smith, David E Arterburn, Mary K Theis
Annals of Internal Medicine. 2025-03-01 - Associations between dementia and exposure to topical glaucoma medications.Oliver Davidson, Michael L Lee, Jason P Kam, Michael Brush, Anand Rajesh
Journal of Alzheimer's Disease. 2025-02-01
Journal Articles
- Geographic Variation in Obesity, Behavioral Treatment, and Bariatric Surgery for VeteransLuke M Funk, David E Arterburn, Obesity
- Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients with Type 2 Diabetes and Severe ObesityDavid Arterburn, Stephen Sidney, JAMA
- Microvascular Outcomes in Patients with Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort StudyStephen Sidney, David Arterburn, Annals of Internal Medicine
Press Mentions
What Is Gastric Sleeve Surgery?April 19th, 2023- Long-Term Costs, Outcomes of Sleeve Gastrectomy vs Roux-en-YSeptember 9th, 2021
- Metabolic Disorders Trends: Obesity Leads Twitter Mentions in Q4 2020March 29th, 2021
- Join now to see all
Grant Support
- Comparative Effectiveness and Safety of Metabolic/Bariatric Surgery, GLP-1, and SGLT-2 Medications for Patients with Obesity and Type 2 DiabetesKAISER FOUNDATION RESEARCH INSTITUTE2024–2028
- Developing robust anti-Obesity Medication ImplemeNtatiOn approaches to maximize population health (the DOMINO study)DUKE UNIVERSITY2024–2028
- Developing robust anti-Obesity Medication ImplemeNtatiOn approaches to maximize population health (the DOMINO study)DUKE UNIVERSITY2024–2028
- Long-term Costs and Return on Investment for Bariatric SurgeryDUKE UNIVERSITY2020–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
